Exclusive Webinar :Don't miss the latest webinar on Global Investing with Passive Products on June 22, 11am

Buy Laurus Labs: target of Rs 410: Sharekhan

Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 410 in its research report dated December 22, 2020.

December 23, 2020 / 01:15 PM IST
  • bselive
  • nselive
Todays L/H

Sharekhan's research report on Laurus Labs

Formulations business gaining traction with tender business witnessing sturdy demand traction. Custom synthesis business is also expected to clock double-digit growth over FY2020-FY2023 backed by expanded capacities and increasing commencement of commercial supplies. Further, the company’s foray in the lucrative biologics/biotech space through the acquisition of a majority stake in Richcore Lifesciences would be a key positive as it would create a new revenue stream.


We retain a Buy recommendation on Laurus Labs Limited (Laurus) with a revised PT of Rs. 410.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Dec 23, 2020 01:15 pm

stay updated

Get Daily News on your Browser